Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Compass Therapeutics Inc | Thomas J. Schuetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 1,500,000 | 1,500,000 | - | - | Stock Option (Right to Buy) | |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 647,311 | 1,294,622 (0%) | 0% | 0 | Common Stock | |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 647,311 | 0 (0%) | 0% | 0 | Common Stock | |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 647,311 | 647,311 (0%) | 0% | 0 | Common Stock | |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 647,311 | 1,294,622 (0%) | 0% | 0 | Common Stock | |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 647,311 | 0 (0%) | 0% | 0 | Common Stock | |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 647,311 | 647,311 (0%) | 0% | 0 | Common Stock | |
| Doximity Inc - Ordinary Sh... | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 75.33 per share. | 11 Feb 2025 | 474,448 | 2,117,992 | - | 75.3 | 35,738,080 | Class A Common Stock |
| Nurix Therapeutics Inc | Arthur T. Sands | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 450,000 | 450,000 | - | - | Employee Stock Option (right to buy) | |
| Trade Desk Inc - Ordinary ... | Jeffrey Terry Green | Director, President and CEO, Ten Percent Owner | 11 Feb 2025 | 360,000 | 363,700 (0%) | 0% | 0 | Class A Common Stock | ||
| Trade Desk Inc - Ordinary ... | Jeffrey Terry Green | Director, President and CEO, Ten Percent Owner | 11 Feb 2025 | 360,000 | 29,599,258 | - | - | Class B Common Stock | ||
| Ocular Therapeutix Inc | Donald Notman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 344,115 | 344,115 | - | - | Stock Option (Right to Buy) | |
| C3.ai Inc - Ordinary Share... | Thomas M. Siebel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.43 per share. | 11 Feb 2025 | 334,227 | 1,555,163 | - | 32.4 | 10,838,982 | Class A Common Stock |
| Ocular Therapeutix Inc | Sanjay Nayak | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 334,000 | 334,000 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 332,465 | 958,413 | - | 0 | Common Stock | |
| Stryker Corp. | Ronda E. Stryker | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 307,691 | 3,299,776 (0%) | 0% | 0 | Common Stock | |
| scPharmaceuticals Inc | John H. Tucker | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| FirstCash Holdings Inc | Douglas R. Rippel | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 113.43 per share. | 11 Feb 2025 | 300,000 | 4,431,869 (10%) | 0% | 113.4 | 34,029,000 | Common Stock |
| Aflac Inc. | Daniel P. Amos | Director, Chairman of the Board, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 294,981 | 962,770 (0%) | 0% | 0 | Common Stock | |
| Compass Therapeutics Inc | Jonathan Anderman | Sr VP, Gen Counsel & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 280,000 | 280,000 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc - Ordinary Sh... | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 74.86 per share. | 11 Feb 2025 | 260,624 | 2,619,873 | - | 74.9 | 19,511,407 | Class A Common Stock |
| Trade Desk Inc - Ordinary ... | Jeffrey Terry Green | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 120.47 per share. | 11 Feb 2025 | 256,075 | 107,625 (0%) | 0% | 120.5 | 30,849,355 | Class A Common Stock |
| JELD-WEN Holding Inc. | William Christensen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 252,383 | 252,383 | - | - | Common Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Barry Shin | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Gaurav Shah | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 243,345 | 243,345 | - | - | Stock Option (Right to Buy) | |
| Essential Properties Realt... | Peter M. Mavoides | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 238,185 | 555,974 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 237,000 | 237,000 | - | - | Stock Option (Right to Buy) | |
| Canopy Growth Corporation | Luc Mongeau | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 225,000 | 225,000 | - | - | Stock Option | |
| Compass Inc - Ordinary Sha... | Robert Reffkin | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 7.90 per share. | 11 Feb 2025 | 224,510 | 1,139,136 | - | 7.9 | 1,774,258 | Class A Common Stock |
| scPharmaceuticals Inc | John H. Tucker | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 200,000 | 440,847 (2%) | 1% | 0 | Common Stock | |
| Compass Therapeutics Inc | Neil Lerner | SVP, CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc - Ordinary Sh... | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 200,000 | 0 | - | 0 | Class A Common Stock | |
| ThredUp Inc - Ordinary Sha... | Patricia Nakache | Director | 11 Feb 2025 | 186,714 | 186,714 | - | 0 | Class A Common Stock | ||
| ThredUp Inc - Ordinary Sha... | Patricia Nakache | Director | 11 Feb 2025 | 186,714 | 2,919,337 | - | - | Class B Common Stock | ||
| ThredUp Inc - Ordinary Sha... | Patricia Nakache | Director | Sale of securities on an exchange or to another person at price $ 2.57 per share. | 11 Feb 2025 | 186,714 | 0 | - | 2.6 | 479,855 | Class A Common Stock |
| Oramed Pharmaceuticals, Inc | Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 186,000 | 2,586,598 (14%) | 1% | 0 | Common Stock | |
| Doximity Inc - Ordinary Sh... | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | 11 Feb 2025 | 178,334 | 3,058,831 | - | - | Class A Common Stock | ||
| Doximity Inc - Ordinary Sh... | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 178,334 | 4,100,000 | - | - | Class B Common Stock | |
| Doximity Inc - Ordinary Sh... | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | 11 Feb 2025 | 178,334 | 3,921,666 | - | - | Class B Common Stock | ||
| Rocket Pharmaceuticals Inc | Kinnari Patel | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 172,214 | 172,214 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc - Ordinary Sh... | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 75.83 per share. | 11 Feb 2025 | 159,108 | 2,899,723 | - | 75.8 | 12,065,526 | Class A Common Stock |
| JFrog Ltd | Shlomi Ben Haim | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 157,274 | 5,024,083 | - | 0 | Ordinary Shares | |
| JELD-WEN Holding Inc. | William Christensen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 152,545 | 385,154 (0%) | 0% | 0 | Common Stock | |
| Freeport-McMoRan Inc | Richard C. Adkerson | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 151,875 | 4,000,925 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | Hazel Hunt | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 150,000 | 0 | - | - | Stock Option (right to buy) | |
| Corcept Therapeutics Inc | Hazel Hunt | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.29 per share. | 11 Feb 2025 | 150,000 | 268,581 (0%) | 0% | 3.3 | 493,500 | Common Stock |
| OneSpaWorld Holdings Limited | Leonard I. Fluxman | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 141,792 | 1,705,852 (2%) | 0% | - | Common Shares | |
| Halliburton Co. | Eric J. Carre | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.13 per share. | 11 Feb 2025 | 141,206 | 127,101 (0%) | 0% | 26.1 | 3,689,713 | Common Stock |
| Oramed Pharmaceuticals, Inc | Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 141,000 | 2,400,598 (13%) | 0% | 0 | Common Stock | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.85 per share. | 11 Feb 2025 | 140,182 | 625,948 | - | 3.9 | 539,701 | Common Stock |
| JFrog Ltd | Tali Notman | CHIEF REVENUE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 139,738 | 722,132 | - | 0 | Ordinary Shares | |
| Amicus Therapeutics Inc | Bradley L. Campbell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 137,075 | 1,220,768 (0%) | 0% | 0 | Common Stock | |
| U.S. Bancorp. | Andrew Cecere | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 134,896 | 1,365,212 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Rocket Pharmaceuticals Inc | Martin Wilson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 134,642 | 134,642 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Aaron Ondrey | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 134,642 | 134,642 | - | - | Stock Option (Right to Buy) | |
| C3.ai Inc - Ordinary Share... | Thomas M. Siebel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.86 per share. | 11 Feb 2025 | 133,000 | 1,889,390 | - | 1.9 | 247,380 | Class A Common Stock |
| C3.ai Inc - Ordinary Share... | Thomas M. Siebel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 133,000 | 0 | - | - | Stock Option (Right to Buy) | |
| scPharmaceuticals Inc | Rachael Nokes | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 132,670 | 132,670 | - | - | Stock Option (Right to Buy) | |
| Aflac Inc. | Daniel P. Amos | Director, Chairman of the Board, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.61 per share. | 11 Feb 2025 | 130,511 | 832,259 (0%) | 0% | 102.6 | 13,391,734 | Common Stock |
| Boston Scientific Corp. | Michael F. Mahoney | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 130,118 | 1,682,788 (0%) | 0% | 0 | Common Stock | |
| Tenet Healthcare Corp. | Saumya Sutaria | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 126,203 | 397,724 (0%) | 0% | 0 | Common Stock | |
| C3.ai Inc - Ordinary Share... | Thomas M. Siebel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.37 per share. | 11 Feb 2025 | 120,748 | 1,336,968 | - | 34.4 | 4,150,109 | Class A Common Stock |
| EverQuote Inc - Ordinary S... | Jayme Mendal | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 120,504 | 507,742 (4%) | 0% | 0 | Class A Common Stock | |
| Rocket Pharmaceuticals Inc | Jonathan Schwartz | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 119,682 | 119,682 | - | - | Stock Option (Right to Buy) | |
| Airbnb Inc - Ordinary Shar... | Joseph Gebbia | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 135.26 per share. | 11 Feb 2025 | 115,714 | 646,065 | - | 135.3 | 15,651,244 | Class A Common Stock |
| Ocular Therapeutix Inc | Donald Notman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 115,000 | 308,444 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Sanjay Nayak | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 111,000 | 285,380 (0%) | 0% | 0 | Common Stock | |
| First Citizens Bancshares,... | Frank B. Holding | Director, Chairman and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 110,142 | 414,741 (4%) | 1% | 0 | Class A Common | |
| First Citizens Bancshares,... | Frank B. Holding | Director, Chairman and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 110,142 | 118,728 (1%) | 1% | 0 | Class A Common | |
| Upbound Group Inc | Mitchell E. Fadel | Director, Chief Executive Officer | 11 Feb 2025 | 110,001 | 832,047 (1%) | 0% | 29.5 | 3,245,030 | COMMON STOCK | |
| CNO Financial Group Inc | Gary C. Bhojwani | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 37.95 per share. | 11 Feb 2025 | 101,483 | 323,302 (0%) | 0% | 38.0 | 3,851,280 | Common Stock |
| Trade Desk Inc - Ordinary ... | Jeffrey Terry Green | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 121.16 per share. | 11 Feb 2025 | 100,205 | 7,420 (0%) | 0% | 121.2 | 12,140,838 | Class A Common Stock |
| Oramed Pharmaceuticals, Inc | Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 100,000 | 2,686,598 (15%) | 0% | 0 | Common Stock | |
| Doximity Inc - Ordinary Sh... | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Peraso Inc | Mark A. Lunsford | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Peraso Inc | James Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Peraso Inc | Ronald Glibbery | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Peraso Inc | Brad Lynch | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Peraso Inc | Alexander Tomkins | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| First Horizon Corporation | D. Bryan Jordan | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 99,188 | 1,960,569 (0%) | 0% | 0 | Common Stock | |
| TTM Technologies Inc | Thomas T. Edman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 97,496 | 914,291 (0%) | 0% | 0 | Common Stock | |
| C3.ai Inc - Ordinary Share... | Thomas M. Siebel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.49 per share. | 11 Feb 2025 | 97,447 | 1,457,716 | - | 33.5 | 3,263,500 | Class A Common Stock |
| Airbnb Inc - Ordinary Shar... | Joseph Gebbia | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 134.73 per share. | 11 Feb 2025 | 95,366 | 761,779 | - | 134.7 | 12,848,776 | Class A Common Stock |
| Doximity Inc - Ordinary Sh... | Anna Bryson | Chief Financial Officer | 11 Feb 2025 | 95,000 | 424,386 | - | - | Class A Common Stock | ||
| Doximity Inc - Ordinary Sh... | Anna Bryson | Chief Financial Officer | 11 Feb 2025 | 95,000 | 0 | - | - | Class B Common Stock | ||
| Doximity Inc - Ordinary Sh... | Anna Bryson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 95,000 | 95,000 | - | - | Class B Common Stock | |
| Doximity Inc - Ordinary Sh... | Anna Bryson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 95,000 | 382,268 | - | - | Stock Option (Right to Buy) | |
| Taylor Morrison Home Corp. | Sheryl D. Palmer | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 90,784 | 382,377 (0%) | 0% | 0 | Common Stock | |
| Taylor Morrison Home Corp. | Sheryl D. Palmer | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 90,784 | 90,784 | - | - | Performance-based restricted stock units | |
| Taylor Morrison Home Corp. | Sheryl D. Palmer | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 90,784 | 0 | - | - | Performance-based restricted stock units | |
| Rocket Pharmaceuticals Inc | Martin Wilson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 90,358 | 153,918 (0%) | 0% | 0 | Common Stock | |
| Rocket Pharmaceuticals Inc | Aaron Ondrey | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 90,358 | 137,139 (0%) | 0% | 0 | Common Stock | |
| Alignment Healthcare Inc | John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.23 per share. | 11 Feb 2025 | 90,000 | 2,183,100 | - | 14.2 | 1,280,304 | Common Stock |
| Aflac Inc. | Daniel P. Amos | Director, Chairman of the Board, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 89,800 | 742,459 (0%) | 0% | 0 | Common Stock | |
| Freeport-McMoRan Inc | Kathleen L. Quirk | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 89,250 | 2,213,344 (0%) | 0% | 0 | Common Stock | |
| AvePoint Inc - Ordinary Sh... | Jeffrey E. Epstein | Director | Grant, award, or other acquisition of securities at price $ 19.49 per share. | 11 Feb 2025 | 88,738 | 1,657,891 | - | 19.5 | 1,729,504 | Common Stock |
| scPharmaceuticals Inc | Rachael Nokes | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 88,445 | 156,061 (0%) | 0% | 0 | Common Stock | |
| ThredUp Inc - Ordinary Sha... | Patricia Nakache | Director | Sale of securities on an exchange or to another person at price $ 2.51 per share. | 11 Feb 2025 | 85,461 | 0 | - | 2.5 | 214,507 | Class A Common Stock |
| ThredUp Inc - Ordinary Sha... | Patricia Nakache | Director | 11 Feb 2025 | 85,461 | 85,461 | - | 0 | Class A Common Stock | ||
| ThredUp Inc - Ordinary Sha... | Patricia Nakache | Director | 11 Feb 2025 | 85,461 | 2,833,876 | - | - | Class B Common Stock | ||
| Corcept Therapeutics Inc | Hazel Hunt | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.11 per share. | 11 Feb 2025 | 85,176 | 183,405 (0%) | 0% | 68.1 | 5,801,337 | Common Stock |
| CNO Financial Group Inc | Gary C. Bhojwani | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 37.95 per share. | 11 Feb 2025 | 83,000 | 364,941 | - | 38.0 | 3,149,850 | Restricted Stock Units |
| Unisys Corp. | Peter A. Altabef | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 81,790 | 1,510,150 (2%) | 0% | 0 | Common Stock | |
| Rocket Pharmaceuticals Inc | Gaurav Shah | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 81,655 | 788,983 (1%) | 0% | 0 | Common Stock | |
| Rocket Pharmaceuticals Inc | Jonathan Schwartz | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 80,318 | 252,731 (0%) | 0% | 0 | Common Stock | |
| Dana Inc | Timothy R. Kraus | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 79,608 | 79,608 | - | - | Restricted Stock Units | |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 79,000 | 220,666 (0%) | 0% | 0 | Common Stock | |
| C3.ai Inc - Ordinary Share... | Thomas M. Siebel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.22 per share. | 11 Feb 2025 | 78,873 | 1,258,095 | - | 32.2 | 2,541,288 | Class A Common Stock |
| Freeport-McMoRan Inc | Kathleen L. Quirk | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 77,000 | 2,124,094 (0%) | 0% | 0 | Common Stock | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.70 per share. | 11 Feb 2025 | 75,324 | 883,089 | - | 3.7 | 278,699 | Common Stock |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| JFrog Ltd | Eduard Grabscheid | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 74,526 | 168,123 | - | 0 | Ordinary Shares | |
| Oramed Pharmaceuticals, Inc | Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 74,000 | 1,074,666 (6%) | 0% | 0 | Common Stock | |
| Royal Caribbean Group | Jason T. Liberty | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 71,580 | 207,891 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Bradley L. Campbell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.57 per share. | 11 Feb 2025 | 70,711 | 1,150,657 (0%) | 0% | 9.6 | 676,704 | Common Stock |
| SentinelOne Inc - Ordinary... | Tomer Weingarten | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 24.22 per share. | 11 Feb 2025 | 70,642 | 939,726 | - | 24.2 | 1,710,963 | Class A Common Stock |
| Doximity Inc - Ordinary Sh... | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 70,000 | 776,000 | - | - | Stock Option (Right to Buy) | |
| JELD-WEN Holding Inc. | Samantha Stoddard L. | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 69,382 | 69,382 | - | - | Common Stock Option (Right to Buy) | |
| Ingredion Inc | James P. Zallie | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 68,516 | 121,273 (0%) | 0% | 0 | Common Stock | |
| Oramed Pharmaceuticals, Inc | Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 66,667 | 1,193,333 (6%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 64,800 | 536,294 (0%) | 0% | 0 | Common Stock | |
| Aflac Inc. | Audrey Boone Tillman | Sr. Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 62,938 | 285,556 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Michael F. Mahoney | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 11 Feb 2025 | 62,915 | 1,619,873 (0%) | 0% | 106.0 | 6,667,732 | Common Stock |
| SentinelOne Inc - Ordinary... | Tomer Weingarten | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 60,864 | 4,284,517 | - | - | Class B Common Stock | |
| SentinelOne Inc - Ordinary... | Tomer Weingarten | Director, President, CEO | 11 Feb 2025 | 60,864 | 1,010,368 | - | 9.7 | 592,815 | Class A Common Stock | |
| SentinelOne Inc - Ordinary... | Tomer Weingarten | Director, President, CEO | 11 Feb 2025 | 60,864 | 4,223,653 | - | - | Class B Common Stock | ||
| SentinelOne Inc - Ordinary... | Tomer Weingarten | Director, President, CEO | 11 Feb 2025 | 60,864 | 4,223,653 | - | - | Class B Common Stock | ||
| SentinelOne Inc - Ordinary... | Tomer Weingarten | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 60,864 | 3,843,234 | - | - | Employee Stock Option (right to buy) | |
| SentinelOne Inc - Ordinary... | Tomer Weingarten | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 60,864 | 4,284,517 | - | - | Class B Common Stock | |
| SentinelOne Inc - Ordinary... | Tomer Weingarten | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 60,864 | 3,904,098 | - | - | Employee Stock Option (right to buy) | |
| SentinelOne Inc - Ordinary... | Tomer Weingarten | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 23.98 per share. | 11 Feb 2025 | 60,864 | 939,726 | - | 24.0 | 1,459,440 | Class A Common Stock |
| SentinelOne Inc - Ordinary... | Tomer Weingarten | Director, President, CEO | 11 Feb 2025 | 60,864 | 1,000,590 | - | 9.7 | 592,815 | Class A Common Stock | |
| Essential Properties Realt... | Peter M. Mavoides | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.20 per share. | 11 Feb 2025 | 60,742 | 495,232 (0%) | 0% | 31.2 | 1,895,150 | Common Stock |
| Dana Inc | Byron S. Foster | Pres, Light Veh Drive Systems | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 60,624 | 60,624 | - | - | Restricted Stock Units | |
| Doximity Inc - Ordinary Sh... | Anna Bryson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 75.93 per share. | 11 Feb 2025 | 60,503 | 347,728 | - | 75.9 | 4,594,011 | Class A Common Stock |
| JELD-WEN Holding Inc. | Gustavo Vianna | EVP & President, Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 60,334 | 60,334 | - | - | Common Stock Option (Right to Buy) | |
| Samsara Inc - Ordinary Sha... | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 55.30 per share. | 11 Feb 2025 | 59,358 | 1,167,201 | - | 55.3 | 3,282,634 | Class A Common Stock |
| Samsara Inc - Ordinary Sha... | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 55.30 per share. | 11 Feb 2025 | 59,129 | 1,639,719 | - | 55.3 | 3,269,775 | Class A Common Stock |
| Metallus Inc. | Michael S. Williams | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 59,120 | 695,345 (1%) | 0% | 0 | Common Shares | |
| JELD-WEN Holding Inc. | James S. Hayes | EVP, GC & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 58,586 | 58,586 | - | - | Common Stock Option (Right to Buy) | |
| Natural Resource Partners ... | Corbin J. Robertson | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 58,050 | 726,798 (5%) | 0% | - | COMMON UNITS | |
| Rocket Pharmaceuticals Inc | Kinnari Patel | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 57,786 | 450,181 (0%) | 0% | 0 | Common Stock | |
| Conoco Phillips | Ryan M. Lance | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 57,384 | 57,384 | - | - | Stock Units | |
| OneSpaWorld Holdings Limited | Stephen B. Lazarus | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 57,092 | 338,098 (0%) | 0% | - | Common Shares | |
| Freeport-McMoRan Inc | Richard C. Adkerson | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 57,000 | 3,849,050 (0%) | 0% | 0 | Common Stock | |
| U.S. Bancorp. | Terrance R. Dolan | Vice Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 56,656 | 266,138 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Freeport-McMoRan Inc | Richard C. Adkerson | Director, Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.46 per share. | 11 Feb 2025 | 55,863 | 3,945,062 (0%) | 0% | 38.5 | 2,148,491 | Common Stock |
| Unisys Corp. | Michael M. Thomson | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 55,022 | 438,242 (0%) | 0% | 0 | Common Stock | |
| TTM Technologies Inc | Thomas T. Edman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.55 per share. | 11 Feb 2025 | 54,478 | 859,813 (0%) | 0% | 25.6 | 1,392,087 | Common Stock |
| Aflac Inc. | Max K. Broden | Sr. EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 53,583 | 152,765 (0%) | 0% | 0 | Common Stock | |
| Skechers U S A, Inc. - Ord... | Robert Greenberg | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.90 per share. | 11 Feb 2025 | 53,466 | 113,967 (0%) | 0% | 63.9 | 3,416,477 | Class A Common Stock |
| JELD-WEN Holding Inc. | Wendy A. Livingston | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 52,790 | 52,790 | - | - | Common Stock Option (Right to Buy) | |
| Skechers U S A, Inc. - Ord... | Robert Greenberg | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 62.72 per share. | 11 Feb 2025 | 52,600 | 61,367 (0%) | 0% | 62.7 | 3,298,935 | Class A Common Stock |
| Amicus Therapeutics Inc | Jeff Castelli | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 52,338 | 488,200 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 52,338 | 368,854 (0%) | 0% | 0 | Common Stock | |
| Ladder Capital Corp - Ordi... | Pamela McCormack | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.06 per share. | 11 Feb 2025 | 52,230 | 145,423 (0%) | 0% | 11.1 | 577,664 | Class A Common Stock |
| Oramed Pharmaceuticals, Inc | Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 52,000 | 1,126,666 (6%) | 0% | 0 | Common Stock | |
| Royal Caribbean Group | Michael W. Bayley | Pres&CEO, Royal Caribbean Intl | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 51,128 | 94,794 (0%) | 0% | 0 | Common Stock | |
| Southern Company | Christopher C. Womack | CEO, President and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 50,587 | 133,993 (0%) | 0% | 0 | Southern Company Common Stock | |
| Roblox Corporation - Ordin... | Anthony P. Lee | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 50,000 | 6,610,957 | - | 0 | Class A Common Stock | |
| Boyd Gaming Corp. | Marianne Boyd Johnson | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 77.68 per share. | 11 Feb 2025 | 50,000 | 1,346,628 (1%) | 0% | 77.7 | 3,884,000 | Common Stock |
| Canopy Growth Corporation | Luc Mongeau | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 50,000 | 57,687 (0%) | 0% | 0 | Common Shares | |
| CTO Realty Growth Inc - Or... | John P. Albright | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 49,802 | 609,997 (12%) | 1% | 0 | Common Stock | |
| Boyd Gaming Corp. | Marianne Boyd Johnson | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 77.59 per share. | 11 Feb 2025 | 49,800 | 1,296,828 (1%) | 0% | 77.6 | 3,863,982 | Common Stock |
| EverQuote Inc - Ordinary S... | David Brainard | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 49,451 | 157,695 (1%) | 0% | 0 | Class A Common Stock | |
| Oramed Pharmaceuticals, Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 48,500 | 799,833 (4%) | 0% | 0 | Common Stock | |
| EverQuote Inc - Ordinary S... | Joseph Sanborn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 47,453 | 240,582 (1%) | 0% | 0 | Class A Common Stock | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 47,000 | 47,000 | - | - | Stock Option (Right to Buy) | |
| Samsara Inc - Ordinary Sha... | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 55.77 per share. | 11 Feb 2025 | 45,453 | 1,115,751 | - | 55.8 | 2,534,777 | Class A Common Stock |
| Samsara Inc - Ordinary Sha... | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 55.77 per share. | 11 Feb 2025 | 45,434 | 1,587,924 | - | 55.8 | 2,534,045 | Class A Common Stock |
| Kelly Services, Inc. - Ord... | Peter W. Quigley | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 45,340 | 460,233 (1%) | 0% | 0 | Class A Common Stock, Par Value $1 | |
| Oramed Pharmaceuticals, Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 45,000 | 751,333 (4%) | 0% | 0 | Common Stock | |
| Camden Property Trust | Richard J. Campo | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 119.07 per share. | 11 Feb 2025 | 45,000 | 254,092 (0%) | 0% | 119.1 | 5,358,150 | Common Shares |
| U.S. Bancorp. | Gunjan Kedia | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 43,841 | 275,470 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Aflac Inc. | Masatoshi Koide | Pres. and Rep. Director, ALIJ | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 43,805 | 129,895 (0%) | 0% | 0 | Common Stock | |
| ThredUp Inc - Ordinary Sha... | Patricia Nakache | Director | Sale of securities on an exchange or to another person at price $ 2.67 per share. | 11 Feb 2025 | 43,682 | 0 | - | 2.7 | 116,631 | Class A Common Stock |
| ThredUp Inc - Ordinary Sha... | Patricia Nakache | Director | 11 Feb 2025 | 43,682 | 43,682 | - | 0 | Class A Common Stock | ||
| ThredUp Inc - Ordinary Sha... | Patricia Nakache | Director | 11 Feb 2025 | 43,682 | 2,790,194 | - | - | Class B Common Stock | ||
| Upbound Group Inc | Mitchell E. Fadel | Director, Chief Executive Officer | 11 Feb 2025 | 43,365 | 788,682 (1%) | 0% | 29.5 | 1,279,268 | COMMON STOCK | |
| Dana Inc | Brian Pour | SVP & Pres Comm Veh Drive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 43,057 | 43,057 | - | - | Restricted Stock Units | |
| JELD-WEN Holding Inc. | Matthew Meier | EVP, CDIO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 42,957 | 42,957 | - | - | Common Stock Option (Right to Buy) | |
| Okta Inc - Ordinary Shares... | Todd McKinnon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 42,021 | 42,021 (0%) | 0% | 0 | Class A Common Stock | |
| Oramed Pharmaceuticals, Inc | Avraham Gabay | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 42,000 | 434,040 (2%) | 0% | 0 | Common Stock | |
| JELD-WEN Holding Inc. | Samantha Stoddard L. | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 41,936 | 117,317 (0%) | 0% | 0 | Common Stock | |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 41,667 | 0 | - | - | Nonqualified Stock Option (right to buy) | |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 41,667 | 41,667 | - | - | Nonqualified Stock Option (right to buy) | |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.81 per share. | 11 Feb 2025 | 41,667 | 51,470,600 (29%) | 0% | 9.8 | 408,837 | Common Stock |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.81 per share. | 11 Feb 2025 | 41,667 | 51,451,633 (29%) | 0% | 9.8 | 408,837 | Common Stock |
| Essential Properties Realt... | Mark Patten | Executive VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 41,540 | 143,382 (0%) | 0% | 0 | Common Stock | |
| Otter Tail Corporation | Charles S. Macfarlane | President & CEO | Grant, award, or other acquisition of securities at price $ 79.62 per share. | 11 Feb 2025 | 41,440 | 241,930 (0%) | 0% | 79.6 | 3,299,246 | Common Stock |
| Aflac Inc. | Charles Ditmars Lake | Chairman & Rep. Director, ALIJ | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 41,412 | 102,934 (0%) | 0% | 0 | Common Stock | |
| CNO Financial Group Inc | Gary C. Bhojwani | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.95 per share. | 11 Feb 2025 | 41,361 | 281,941 (0%) | 0% | 38.0 | 1,569,650 | Common Stock |
| ManpowerGroup | Jonas Prising | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,870 | 40,870 (0%) | 0% | - | Common Stock | |
| ManpowerGroup | Jonas Prising | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 40,870 | 0 | - | - | Restricted Stock Units | |
| Dana Inc | Douglas H. Liedberg | SVP, General Counsel and Secty | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,814 | 40,814 | - | - | Restricted Stock Units | |
| OneSpaWorld Holdings Limited | Susan Bonner | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,796 | 267,792 (0%) | 0% | - | Common Shares | |
| i3 Verticals Inc - Ordinar... | Clay Whitson | Director, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 66,168 (0%) | 0% | 0 | Class A common stock, par value $0.0001 per share | |
| i3 Verticals Inc - Ordinar... | Frederick Stanford | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 (0%) | 0% | 0 | Class A common stock, par value $0.0001 per share | |
| i3 Verticals Inc - Ordinar... | Geoff Smith | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 63,404 (0%) | 0% | 0 | Class A common stock, par value $0.0001 per share | |
| i3 Verticals Inc - Ordinar... | Paul Christians | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 45,000 (0%) | 0% | 0 | Class A common stock, par value $0.0001 per share | |
| Compass Therapeutics Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Ellen V. Chiniara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Richard S. Lindahl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Mary Ann Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Philip J. Ferneau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | James P. Boylan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc - Ordinary Sh... | Regina M. Benjamin | Director | 11 Feb 2025 | 40,000 | 0 | - | - | Class B Common Stock | ||
| Doximity Inc - Ordinary Sh... | Regina M. Benjamin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Class B Common Stock | |
| Doximity Inc - Ordinary Sh... | Regina M. Benjamin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 381,138 | - | - | Stock Option (Right to Buy) | |
| Doximity Inc - Ordinary Sh... | Regina M. Benjamin | Director | 11 Feb 2025 | 40,000 | 56,618 | - | - | Class A Common Stock | ||
| Inspired Entertainment Inc | A. Lorne Weil | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Performance Restricted Stock Units | |
| Inspired Entertainment Inc | A. Lorne Weil | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Restricted Stock Units | |
| Unisys Corp. | Peter A. Altabef | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 39,530 | 1,428,360 (2%) | 0% | 0 | Common Stock | |
| EverQuote Inc - Ordinary S... | Julia Brncic | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 39,336 | 144,414 (1%) | 0% | 0 | Class A Common Stock | |
| JFrog Ltd | Tali Notman | CHIEF REVENUE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 39,319 | 761,451 | - | 0 | Ordinary Shares | |
| Delta Air Lines, Inc. | Rahul D. Samant | EVP & Chief Info Officer | Sale of securities on an exchange or to another person at price $ 64.89 per share. | 11 Feb 2025 | 38,023 | 52,789 (0%) | 0% | 64.9 | 2,467,312 | Common Stock |
| Unisys Corp. | Debra McCann W. | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 37,991 | 266,511 (0%) | 0% | 0 | Common Stock | |
| TTM Technologies Inc | Philip Titterton | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 36,981 | 194,509 (0%) | 0% | 0 | Common Stock | |
| JELD-WEN Holding Inc. | Gustavo Vianna | EVP & President, Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 36,467 | 51,522 (0%) | 0% | 0 | Common Stock | |
| Caterpillar Inc. | D. James Umpleby | Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 36,126 | 502,422 (0%) | 0% | 0 | Common Stock | |
| Skechers U S A, Inc. - Ord... | David Weinberg | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 62.72 per share. | 11 Feb 2025 | 36,000 | 54,499 (0%) | 0% | 62.7 | 2,257,826 | Class A Common Stock |
| TEGNA Inc | Lynn Beall | EVP and COO, Media Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 35,990 | 35,990 | - | - | 2023 Performance Shares | |
| Central Garden & Pet Co. | John E. Hanson | President Pet Consumer Product | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 35,682 | 62,945 (0%) | 0% | 0 | Class A Common Stock | |
| Taylor Morrison Home Corp. | Sheryl D. Palmer | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.39 per share. | 11 Feb 2025 | 35,629 | 346,748 (0%) | 0% | 62.4 | 2,222,893 | Common Stock |
| JELD-WEN Holding Inc. | James S. Hayes | EVP, GC & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 35,410 | 107,281 (0%) | 0% | 0 | Common Stock | |
| Enact Holdings Inc | Rohit Gupta | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 35,326 | 0 | - | - | Restricted Stock Units | |
| Enact Holdings Inc | Rohit Gupta | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 35,326 | 287,737 | - | - | Common Stock | |
| U.S. Bancorp. | Jodi L. Richard | Vice Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 35,073 | 134,863 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Skechers U S A, Inc. - Ord... | David Weinberg | Director, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.90 per share. | 11 Feb 2025 | 34,712 | 90,499 (0%) | 0% | 63.9 | 2,218,097 | Class A Common Stock |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 34,300 | 34,300 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 34,300 | 34,300 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 34,300 | 34,300 | - | - | Restricted Stock Units | |
| TTM Technologies Inc | Douglas L. Soder | EVP, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 34,224 | 213,689 (0%) | 0% | 0 | Common Stock | |
| CTO Realty Growth Inc - Or... | John P. Albright | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 34,147 | 624,547 (12%) | 0% | 0 | Common Stock | |
| Oramed Pharmaceuticals, Inc | Avraham Gabay | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 34,000 | 392,040 (2%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Daniel J. Brennan | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 33,944 | 257,865 (0%) | 0% | 0 | Common Stock | |
| Freeport-McMoRan Inc | Kathleen L. Quirk | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.46 per share. | 11 Feb 2025 | 33,451 | 2,179,893 (0%) | 0% | 38.5 | 1,286,525 | Common Stock |
| Oramed Pharmaceuticals, Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 33,334 | 833,167 (4%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 33,100 | 33,100 | - | - | Non-qualified Stock Options | |
| Phillips 66 | Mark E. Lashier | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 129.83 per share. | 11 Feb 2025 | 32,351 | 125,735 (0%) | 0% | 129.8 | 4,200,049 | Common Stock |
| Public Service Enterprise ... | Ralph A. Larossa | Director, Chair, President and CEO | Grant, award, or other acquisition of securities at price $ 83.77 per share. | 11 Feb 2025 | 32,232 | 159,899 (0%) | 0% | 83.8 | 2,700,075 | Common Stock |
| JELD-WEN Holding Inc. | Wendy A. Livingston | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 31,907 | 77,280 (0%) | 0% | 0 | Common Stock | |
| Natural Resource Partners ... | Craig W. Nunez | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 31,549 | 120,889 (0%) | 0% | - | COMMON UNITS | |
| MI Homes Inc. | Robert H. Schottenstein | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 119.65 per share. | 11 Feb 2025 | 31,518 | 343,760 (1%) | 0% | 119.7 | 3,771,129 | Common Shares |
| TTM Technologies Inc | Catherine A. Gridley | EVP, A&D BU President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 31,468 | 146,764 (0%) | 0% | 0 | Common Stock | |
| First Citizens Bancshares,... | Frank B. Holding | Director, Chairman and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 31,241 | 66,208 | - | 0 | Class B Common | |
| First Citizens Bancshares,... | Frank B. Holding | Director, Chairman and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 31,241 | 33,000 | - | 0 | Class B Common | |
| Healthcare Realty Trust In... | Robert E. Hull | EVP and COO | Grant, award, or other acquisition of securities at price $ 16.17 per share. | 11 Feb 2025 | 30,921 | 201,622 (0%) | 0% | 16.2 | 499,993 | Common Stock |
| Okta Inc - Ordinary Shares... | Todd McKinnon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 30,211 | 72,232 (0%) | 0% | 0 | Class A Common Stock | |
| Revelation Biosciences Inc | James Rolke | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 3.87 per share. | 11 Feb 2025 | 30,095 | 30,137 | - | 3.9 | 116,468 | Common Stock |
| First Horizon Corporation | Anthony J. Restel | SEVP, Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 30,093 | 607,514 (0%) | 0% | 0 | Common Stock | |
| First Horizon Corporation | Tammy S. LoCascio | SEVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 30,093 | 333,219 (0%) | 0% | 0 | Common Stock | |
| i3 Verticals Inc - Ordinar... | Paul Maple | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 30,000 | 35,769 (0%) | 0% | 0 | Class A common stock, par value $0.0001 per share | |
| Rocket Pharmaceuticals Inc | John Militello | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 29,920 | 29,920 | - | - | Stock Option (Right to Buy) | |
| TTM Technologies Inc | Daniel J. Weber | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 29,585 | 124,073 (0%) | 0% | 0 | Common Stock | |
| TTM Technologies Inc | Shawn A. Powers | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 29,585 | 118,926 (0%) | 0% | 0 | Common Stock | |
| JFrog Ltd | Frederic Simon | Director | Sale of securities on an exchange or to another person at price $ 35.83 per share. | 11 Feb 2025 | 29,389 | 4,415,043 | - | 35.8 | 1,053,008 | Ordinary Shares |
| Ingredion Inc | James P. Zallie | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.66 per share. | 11 Feb 2025 | 29,187 | 92,086 (0%) | 0% | 128.7 | 3,755,199 | Common Stock |
| Kelly Services, Inc. - Ord... | Troy R. Anderson | Executive Vice President, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 29,018 | 201,262 (0%) | 0% | 0 | Class A Common Stock, Par Value $1 | |
| Palisade Bio Inc | Mitchell Lawrence Jones | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 29,000 | 29,000 | - | - | Stock Option (Right to Buy) | |
| Unisys Corp. | Kristen Prohl | SVP, GC, Secretary & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 28,821 | 125,073 (0%) | 0% | 0 | Common Stock | |
| Trade Desk Inc - Ordinary ... | Jeffrey Terry Green | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 120.47 per share. | 11 Feb 2025 | 28,727 | 685,309 (1%) | 0% | 120.5 | 3,460,742 | Class A Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.57 per share. | 11 Feb 2025 | 28,584 | 507,710 (0%) | 0% | 9.6 | 273,549 | Common Stock |
| Royal Caribbean Group | Jason T. Liberty | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 257.34 per share. | 11 Feb 2025 | 28,166 | 179,725 (0%) | 0% | 257.3 | 7,248,238 | Common Stock |
| Dana Inc | Craig Price | SVP & Pres Off-Highway Drive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 28,130 | 28,130 | - | - | Restricted Stock Units | |
| First Horizon Corporation | Hope Dmuchowski | Sr. EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 28,087 | 131,510 (0%) | 0% | 0 | Common Stock | |
| Natural Resource Partners ... | Corbin J. Robertson | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 28,076 | 0 | - | - | PHANTOM UNITS | |
| Freeport-McMoRan Inc | Maree E. Robertson | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 28,000 | 96,198 (0%) | 0% | 0 | Common Stock | |
| Healthcare Realty Trust In... | Andrew E. Loope | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 16.17 per share. | 11 Feb 2025 | 27,829 | 163,433 (0%) | 0% | 16.2 | 449,995 | Common Stock |
| Healthcare Realty Trust In... | Julie F. Wilson | EVP, Chief Admin. Officer | Grant, award, or other acquisition of securities at price $ 16.17 per share. | 11 Feb 2025 | 27,829 | 160,477 (0%) | 0% | 16.2 | 449,995 | Common Stock |
| Healthcare Realty Trust In... | Ryan E. Crowley | EVP and CIO | Grant, award, or other acquisition of securities at price $ 16.17 per share. | 11 Feb 2025 | 27,829 | 124,875 (0%) | 0% | 16.2 | 449,995 | Common Stock |
| Doximity Inc - Ordinary Sh... | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 75.33 per share. | 11 Feb 2025 | 27,433 | 2,592,440 | - | 75.3 | 2,066,520 | Class A Common Stock |
| Amicus Therapeutics Inc | Samantha Prout L. | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 27,416 | 122,941 (0%) | 0% | 0 | Common Stock | |
| Natural Resource Partners ... | Corbin J. Robertson | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 27,219 | 27,220 | - | - | PHANTOM UNITS | |
| Metallus Inc. | Michael S. Williams | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.61 per share. | 11 Feb 2025 | 27,024 | 668,321 (1%) | 0% | 15.6 | 421,845 | Common Shares |
| U.S. Bancorp. | James L. Chosy | Senior EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 26,979 | 225,106 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| U.S. Bancorp. | Elcio R.T. Barcelos | Senior EVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 26,979 | 99,578 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Aflac Inc. | Audrey Boone Tillman | Sr. Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.61 per share. | 11 Feb 2025 | 26,733 | 258,823 (0%) | 0% | 102.6 | 2,743,073 | Common Stock |
| Unisys Corp. | Michael M. Thomson | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 26,593 | 383,220 (0%) | 0% | 0 | Common Stock | |
| Kelly Services, Inc. - Ord... | Peter W. Quigley | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 26,591 | 394,411 (1%) | 0% | 0 | Class A Common Stock, Par Value $1 | |
| Select Energy Services Inc... | John D. Schmitz | Director, President/CEO | Sale of securities on an exchange or to another person at price $ 13.16 per share. | 11 Feb 2025 | 26,550 | 2,898,578 (3%) | 0% | 13.2 | 349,289 | Class A Common Stock |
| CNO Financial Group Inc | Paul H. McDonough | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 37.95 per share. | 11 Feb 2025 | 26,533 | 196,116 (0%) | 0% | 37.9 | 1,006,927 | Common Stock |
| Freeport-McMoRan Inc | Stephen T. Higgins | EVP & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 26,000 | 130,377 (0%) | 0% | 0 | Common Stock | |
| JELD-WEN Holding Inc. | Matthew Meier | EVP, CDIO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 25,964 | 37,042 (0%) | 0% | 0 | Common Stock | |
| First Horizon Corporation | David T. Popwell | SEVP Sr Strategic Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 25,858 | 545,784 (0%) | 0% | 0 | Common Stock | |
| Inspired Entertainment Inc | Brooks H. Pierce | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 25,826 | 25,826 | - | - | Restricted Stock Units | |
| Inspired Entertainment Inc | Brooks H. Pierce | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 25,826 | 25,826 | - | - | Performance Restricted Stock Units | |
| Tenet Healthcare Corp. | Thomas W. Arnst | EVP, Chief Admin. Officer & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 25,244 | 25,244 (0%) | 0% | 0 | Common Stock | |
| Taylor Morrison Home Corp. | Sheryl D. Palmer | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 25,218 | 0 | - | - | Restricted Stock Units | |
| Taylor Morrison Home Corp. | Sheryl D. Palmer | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 25,218 | 302,147 (0%) | 0% | - | Common Stock | |
| MI Homes Inc. | Robert H. Schottenstein | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 25,073 | 368,833 (1%) | 0% | 0 | Common Shares | |
| Blackboxstocks Inc | Robert L. Winspear | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 25,000 | 68,250 (0%) | 0% | 0 | Common Stock, par value $0.001 | |
| Coinbase Global Inc - Ordi... | Brian Armstrong | Director, Chairman and CEO, Ten Percent Owner | 11 Feb 2025 | 25,000 | 24,131,225 | - | - | Class B Common Stock | ||
| Coinbase Global Inc - Ordi... | Brian Armstrong | Director, Chairman and CEO, Ten Percent Owner | 11 Feb 2025 | 25,000 | 25,526 | - | 0 | Class A Common Stock | ||
| Dime Community Bancshares Inc | Kenneth J. Mahon | Director | Sale of securities on an exchange or to another person at price $ 32.69 per share. | 11 Feb 2025 | 25,000 | 256,880 (0%) | 0% | 32.7 | 817,285 | Common Stock |
| Globe Life Inc | James Matthew Darden | Director, Co-Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 24,890 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Globe Life Inc | James Matthew Darden | Director, Co-Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.60 per share. | 11 Feb 2025 | 24,890 | 63,863 (0%) | 0% | 87.6 | 2,180,364 | Common Stock |
| TTM Technologies Inc | Philip Titterton | EVP & COO | Sale of securities on an exchange or to another person at price $ 25.56 per share. | 11 Feb 2025 | 24,792 | 157,528 (0%) | 0% | 25.6 | 633,594 | Common Stock |
| JFrog Ltd | Yoav Landman | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 37.43 per share. | 11 Feb 2025 | 24,652 | 6,526,901 | - | 37.4 | 922,724 | Ordinary Shares |
| Tractor Supply Co. | Colin W. Yankee | EVP Chief Supply Chain Officer | Sale of securities on an exchange or to another person at price $ 54.15 per share. | 11 Feb 2025 | 24,602 | 33,645 (0%) | 0% | 54.1 | 1,332,198 | Common stock |
| CNO Financial Group Inc | Paul H. McDonough | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 37.95 per share. | 11 Feb 2025 | 24,500 | 212,408 | - | 38.0 | 929,775 | Restricted Stock Units |
| Palisade Bio Inc | Mitchell Lawrence Jones | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 24,000 | 24,000 | - | - | Restricted Stock Units | |
| Boston Scientific Corp. | Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 23,760 | 52,214 (0%) | 0% | 0 | Common Stock | |
| Steel Dynamics Inc. | Glenn A. Pushis | Senior Vice President | Sale of securities on an exchange or to another person at price $ 134.67 per share. | 11 Feb 2025 | 23,649 | 122,140 (0%) | 0% | 134.7 | 3,184,811 | Common Stock |
| Freeport-McMoRan Inc | Douglas N. Currault | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 23,500 | 187,567 (0%) | 0% | 0 | Common Stock | |
| Skechers U S A, Inc. - Ord... | John M. Vandemore | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.90 per share. | 11 Feb 2025 | 23,144 | 75,671 (0%) | 0% | 63.9 | 1,478,902 | Class A Common Stock |
| Insteel Industries, Inc. | H. O. Woltz | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 22,940 | 22,940 | - | - | Option (right to buy) | |
| Natural Resource Partners ... | Corbin J. Robertson | Director, Chairman and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.72 per share. | 11 Feb 2025 | 22,843 | 703,955 (5%) | 0% | 102.7 | 2,346,433 | COMMON UNITS |
| Essential Properties Realt... | A Joseph Peil | EVP & Head of Asset Management | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 22,842 | 95,079 (0%) | 0% | 0 | Common Stock | |
| Doximity Inc - Ordinary Sh... | Regina M. Benjamin | Director | Sale of securities on an exchange or to another person at price $ 75.93 per share. | 11 Feb 2025 | 22,835 | 26,827 | - | 75.9 | 1,733,967 | Class A Common Stock |
| Samsara Inc - Ordinary Sha... | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 55.68 per share. | 11 Feb 2025 | 22,800 | 1,089,559 | - | 55.7 | 1,269,504 | Class A Common Stock |
| Amicus Therapeutics Inc | Jeff Castelli | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.57 per share. | 11 Feb 2025 | 22,724 | 465,476 (0%) | 0% | 9.6 | 217,469 | Common Stock |
| Dana Inc | Timothy R. Kraus | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 16.10 per share. | 11 Feb 2025 | 22,679 | 73,228 (0%) | 0% | 16.1 | 365,132 | Common Stock, par value $0.01 |
| ManpowerGroup | Jonas Prising | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 22,621 | 0 (0%) | 0% | 0 | Common Stock | |
| Southern Company | Christopher C. Womack | CEO, President and Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.87 per share. | 11 Feb 2025 | 22,583 | 111,410 (0%) | 0% | 83.9 | 1,894,036 | Southern Company Common Stock |
| Aflac Inc. | Max K. Broden | Sr. EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.61 per share. | 11 Feb 2025 | 22,535 | 130,230 (0%) | 0% | 102.6 | 2,312,316 | Common Stock |
| Central Garden & Pet Co. | William E. Brown | Director, Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 22,302 | 1,117,834 (2%) | 0% | 0 | Class A Common Stock | |
| Trustmark Corp. | Duane A. Dewey | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 22,162 | 136,008 (0%) | 0% | 0 | Common Stock | |
| JELD-WEN Holding Inc. | Michael A. Leon | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 22,044 | 155,251 (0%) | 0% | 0 | Common Stock | |
| Princeton Bancorp Inc | Martin Tuchman | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 32.71 per share. | 11 Feb 2025 | 22,000 | 629,141 (9%) | 0% | 32.7 | 719,620 | Common Stock |
| Princeton Bancorp Inc | Daniel J. O’Donnell | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 32.71 per share. | 11 Feb 2025 | 22,000 | 8,304 (0%) | 0% | 32.7 | 719,620 | Common Stock |
| i3 Verticals Inc - Ordinar... | Christopher Laisure | President - Public Sector | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 22,000 | 45,700 (0%) | 0% | 0 | Class A common stock, par value $0.0001 per share | |
| Transocean Ltd | James Roderick Mackenzie | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 3.85 per share. | 11 Feb 2025 | 22,000 | 313,072 (0%) | 0% | 3.9 | 84,700 | Registered Shares |
| Royal Caribbean Group | Jason T. Liberty | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 21,489 | 201,214 (0%) | 0% | 0 | Common Stock | |
| C3.ai Inc - Ordinary Share... | Thomas M. Siebel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.58 per share. | 11 Feb 2025 | 20,828 | 1,237,267 | - | 32.6 | 678,576 | Class A Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.57 per share. | 11 Feb 2025 | 20,593 | 348,261 (0%) | 0% | 9.6 | 197,075 | Common Stock |
| Equifax, Inc. | Mark W. Begor | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 20,527 | 143,456 (0%) | 0% | 0 | Common Stock | |
| Kelly Services, Inc. - Ord... | Peter W. Quigley | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 20,482 | 414,893 (1%) | 0% | 0 | Class A Common Stock, Par Value $1 | |
| Doximity Inc - Ordinary Sh... | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 78.05 per share. | 11 Feb 2025 | 20,482 | 200,600 | - | 78.0 | 1,598,577 | Class A Common Stock |
| Buckle, Inc. | Dennis H. Nelson | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 43.42 per share. | 11 Feb 2025 | 20,453 | 1,698,828 (3%) | 0% | 43.4 | 888,102 | Common Stock |
| Otter Tail Corporation | Charles S. Macfarlane | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.62 per share. | 11 Feb 2025 | 20,435 | 221,495 (0%) | 0% | 79.6 | 1,626,933 | Common Stock |
| Boston Scientific Corp. | Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 20,366 | 25,868 (0%) | 0% | 0 | Common Stock | |
| Essential Properties Realt... | Timothy J. Earnshaw | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 20,249 | 62,500 (0%) | 0% | 0 | Common Stock | |
| Samsara Inc - Ordinary Sha... | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 55.30 per share. | 11 Feb 2025 | 20,162 | 600,838 | - | 55.3 | 1,114,892 | Class A Common Stock |
| Samsara Inc - Ordinary Sha... | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 55.29 per share. | 11 Feb 2025 | 20,125 | 600,875 | - | 55.3 | 1,112,756 | Class A Common Stock |
| Royal Caribbean Group | Michael W. Bayley | Pres&CEO, Royal Caribbean Intl | Payment of exercise price or tax liability using portion of securities received from the company at price $ 257.34 per share. | 11 Feb 2025 | 20,118 | 74,676 (0%) | 0% | 257.3 | 5,177,166 | Common Stock |
| Rocket Pharmaceuticals Inc | John Militello | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 20,080 | 68,494 (0%) | 0% | 0 | Common Stock | |
| Dana Inc | Byron S. Foster | Pres, Light Veh Drive Systems | Grant, award, or other acquisition of securities at price $ 16.10 per share. | 11 Feb 2025 | 20,071 | 61,494 (0%) | 0% | 16.1 | 323,143 | Common Stock, par value $0.01 |
| AMKOR Technology Inc. | Roger A. Carolin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.66 per share. | 11 Feb 2025 | 20,000 | 88,392 (0%) | 0% | 5.7 | 113,200 | Common Stock |
| AMKOR Technology Inc. | Roger A. Carolin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.81 per share. | 11 Feb 2025 | 20,000 | 68,392 (0%) | 0% | 6.8 | 136,200 | Common Stock |
| AMKOR Technology Inc. | Roger A. Carolin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 20,000 | 0 | - | - | Director Stock Option (Right to Buy) | |
| AMKOR Technology Inc. | Roger A. Carolin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 20,000 | 0 | - | - | Director Stock Option (Right to Buy) | |
| ON Semiconductor Corp. | Hassane El-Khoury | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.93 per share. | 11 Feb 2025 | 19,829 | 923,136 (0%) | 0% | 47.9 | 950,404 | Common |
| Bellring Brands Inc | Robert V. Vitale | Director | Sale of securities on an exchange or to another person at price $ 76.16 per share. | 11 Feb 2025 | 19,785 | 1,138,457 (2%) | 0% | 76.2 | 1,506,826 | Common Stock |
| Meta Platforms Inc - Ordin... | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 11 Feb 2025 | 19,668 | 19,668 (0%) | 0% | 0 | Class A Common Stock | ||
| Meta Platforms Inc - Ordin... | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 11 Feb 2025 | 19,668 | 192,979,714 | - | - | Class B Common Stock | ||
| JFrog Ltd | Yoav Landman | Director, CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 19,659 | 6,551,553 | - | 0 | Ordinary Shares | |
| CTO Realty Growth Inc - Or... | John P. Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.26 per share. | 11 Feb 2025 | 19,597 | 590,400 (11%) | 0% | 20.3 | 397,035 | Common Stock |
| Kelly Services, Inc. - Ord... | Vanessa P. Williams | SVP, Gen Counsel & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 19,345 | 86,651 (0%) | 0% | 0 | Class A Common Stock, Par Value $1 | |
| Doximity Inc - Ordinary Sh... | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 76.21 per share. | 11 Feb 2025 | 19,226 | 2,880,497 | - | 76.2 | 1,465,127 | Class A Common Stock |
| Metallus Inc. | Kris Westbrooks | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 19,200 | 188,842 (0%) | 0% | 0 | Common Shares | |
| Equifax, Inc. | Jamil Farshchi | EVP, CISO & CTO | Sale of securities on an exchange or to another person at price $ 248.18 per share. | 11 Feb 2025 | 18,911 | 39,252 (0%) | 0% | 248.2 | 4,693,332 | Common Stock |
| MI Homes Inc. | Phillip G. Creek | Director, Ex. Vice President and CFO | Grant, award, or other acquisition of securities at price $ 119.65 per share. | 11 Feb 2025 | 18,910 | 37,455 (0%) | 0% | 119.7 | 2,262,582 | Common Shares |
| OneSpaWorld Holdings Limited | Leonard I. Fluxman | Director, See Remarks | Other type of transaction at price $ 21.83 per share. | 11 Feb 2025 | 18,886 | 1,686,966 (2%) | 0% | 21.8 | 412,346 | Common Shares |
| Arrow Electronics Inc. | Sean J. Kerins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 107.61 per share. | 11 Feb 2025 | 18,586 | 110,719 (0%) | 0% | 107.6 | 2,000,039 | Common Stock |
| ManpowerGroup | Jonas Prising | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.69 per share. | 11 Feb 2025 | 18,249 | 22,621 (0%) | 0% | 55.7 | 1,016,287 | Common Stock |
| Doximity Inc - Ordinary Sh... | Jeffrey Tangney | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 76.90 per share. | 11 Feb 2025 | 18,158 | 221,082 | - | 76.9 | 1,396,361 | Class A Common Stock |
| Freeport-McMoRan Inc | Ellie Mikes | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 18,000 | 61,572 (0%) | 0% | 0 | Common Stock | |
| Martin Midstream Partners ... | C. Scott Massey | Director | Grant, award, or other acquisition of securities at price $ 3.62 per share. | 11 Feb 2025 | 18,000 | 168,478 (0%) | 0% | 3.6 | 65,160 | Common Units |
| Martin Midstream Partners ... | Byron R. Kelley | Director | Grant, award, or other acquisition of securities at price $ 3.62 per share. | 11 Feb 2025 | 18,000 | 152,066 (0%) | 0% | 3.6 | 65,160 | Common Units |
| Martin Midstream Partners ... | James M. Collingsworth | Director | Grant, award, or other acquisition of securities at price $ 3.62 per share. | 11 Feb 2025 | 18,000 | 149,466 (0%) | 0% | 3.6 | 65,160 | Common Units |
| Ladder Capital Corp - Ordi... | Paul J. Miceli | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.06 per share. | 11 Feb 2025 | 17,961 | 201,988 (0%) | 0% | 11.1 | 198,649 | Class A Common Stock |
| Essential Properties Realt... | Robert Max Jenkins | EVP & Head of Investments | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 17,649 | 38,667 (0%) | 0% | 0 | Common Stock | |
| TTM Technologies Inc | Dale Knecht | SVP Information Technology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 17,481 | 98,873 (0%) | 0% | 0 | Common Stock | |
| Dana Inc | Douglas H. Liedberg | SVP, General Counsel and Secty | Grant, award, or other acquisition of securities at price $ 16.10 per share. | 11 Feb 2025 | 17,312 | 128,481 (0%) | 0% | 16.1 | 278,723 | Common Stock, par value $0.01 |
| Plexus Corp. | Todd P. Kelsey | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 17,115 | 97,710 (0%) | 0% | - | Common Stock, $.01 par value | |
| Plexus Corp. | Todd P. Kelsey | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 17,115 | 0 | - | - | Performance Stock Units | |
| CTO Realty Growth Inc - Or... | Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 17,078 | 172,357 (3%) | 0% | 0 | Common Stock | |
| DraftKings Inc. - Ordinary... | Erik Bradbury | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 17,060 | 17,060 | - | - | Restricted Stock Units | |
| CNO Financial Group Inc | Eric R. Johnson | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 37.95 per share. | 11 Feb 2025 | 17,056 | 648,900 (0%) | 0% | 37.9 | 647,275 | Common Stock |
| CNO Financial Group Inc | Matthew J. Zimpfer | General Counsel | Grant, award, or other acquisition of securities at price $ 37.95 per share. | 11 Feb 2025 | 17,056 | 276,721 (0%) | 0% | 37.9 | 647,275 | Common Stock |
| CNO Financial Group Inc | Scott L. Goldberg | President, Consumer Division | Grant, award, or other acquisition of securities at price $ 37.95 per share. | 11 Feb 2025 | 17,056 | 159,360 (0%) | 0% | 37.9 | 647,275 | Common Stock |
| Dana Inc | Antonio Valencia | Pres. Power Technologies Group | Sale or transfer of securities back to the company at price $ 16.10 per share. | 11 Feb 2025 | 17,022 | 0 (0%) | 0% | 16.1 | 274,054 | Common Stock, par value $0.01 |
| Dana Inc | Antonio Valencia | Pres. Power Technologies Group | Grant, award, or other acquisition of securities at price $ 16.10 per share. | 11 Feb 2025 | 17,022 | 17,022 (0%) | 0% | 16.1 | 274,054 | Common Stock, par value $0.01 |
| Conoco Phillips | William L. Bullock | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 16,922 | 16,922 | - | - | Stock Units | |
| Ladder Capital Corp - Ordi... | Robert Perelman | Head of Asset Management | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.06 per share. | 11 Feb 2025 | 16,712 | 334,741 (0%) | 0% | 11.1 | 184,835 | Class A Common Stock |
| Voyager Therapeutics Inc | Alfred W. Sandrock | President & CEO | Sale of securities on an exchange or to another person at price $ 4.45 per share. | 11 Feb 2025 | 16,644 | 308,518 (0%) | 0% | 4.5 | 74,066 | Common Stock |
| Globe Life Inc | James Matthew Darden | Director, Co-Chairman & CEO | Sale of securities on an exchange or to another person at price $ 121.29 per share. | 11 Feb 2025 | 16,618 | 47,245 (0%) | 0% | 121.3 | 2,015,649 | Common Stock |
| TEGNA Inc | Thomas Cox | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 16,610 | 16,610 | - | - | 2023 Performance Shares | |
| JELD-WEN Holding Inc. | Michael A. Leon | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 16,574 | 171,825 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Daniel J. Brennan | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 11 Feb 2025 | 16,414 | 241,451 (0%) | 0% | 106.0 | 1,739,556 | Common Stock |
| Fortinet Inc | Ken Xie | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 108.54 per share. | 11 Feb 2025 | 16,357 | 51,435,276 (29%) | 0% | 108.5 | 1,775,332 | Common Stock |
| U.S. Bancorp. | Mark G. Runkel | Sr. Exec. VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 16,187 | 112,953 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Doximity Inc - Ordinary Sh... | Anna Bryson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 11 Feb 2025 | 16,155 | 408,231 | - | 75.0 | 1,211,594 | Class A Common Stock |
| CTO Realty Growth Inc - Or... | Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 16,090 | 184,289 (3%) | 0% | 0 | Common Stock | |
| Kelly Services, Inc. - Ord... | Peter W. Quigley | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 16,082 | 367,820 (1%) | 0% | 0 | Class A Common Stock, Par Value $1 | |
| Unisys Corp. | Debra McCann W. | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 15,830 | 228,520 (0%) | 0% | 0 | Common Stock | |
| TTM Technologies Inc | Shawn A. Powers | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.55 per share. | 11 Feb 2025 | 15,814 | 103,112 (0%) | 0% | 25.5 | 403,986 | Common Stock |
| TTM Technologies Inc | Douglas L. Soder | EVP, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.55 per share. | 11 Feb 2025 | 15,691 | 197,998 (0%) | 0% | 25.6 | 400,969 | Common Stock |
| TTM Technologies Inc | Catherine A. Gridley | EVP, A&D BU President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.56 per share. | 11 Feb 2025 | 15,558 | 131,206 (0%) | 0% | 25.6 | 397,631 | Common Stock |
| Okta Inc - Ordinary Shares... | Brett Tighe | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 15,493 | 137,973 (0%) | 0% | 0 | Class A Common Stock | |
| Enact Holdings Inc | Rohit Gupta | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.79 per share. | 11 Feb 2025 | 15,438 | 272,299 | - | 33.8 | 521,650 | Common Stock |
| First Horizon Corporation | Elizabeth A. Ardoin | SEVP, Chief Communications Ofc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 15,381 | 311,122 (0%) | 0% | 0 | Common Stock | |
| Royal Caribbean Group | Harri U. Kulovaara | EVP, Maritime | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 15,339 | 35,924 (0%) | 0% | 0 | Common Stock | |
| Natural Resource Partners ... | Craig W. Nunez | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 15,259 | 0 | - | - | PHANTOM UNITS | |
| OneSpaWorld Holdings Limited | Stephen B. Lazarus | CFO and COO | Other type of transaction at price $ 21.83 per share. | 11 Feb 2025 | 15,209 | 322,889 (0%) | 0% | 21.8 | 332,064 | Common Shares |
| Insperity Inc | Paul J. Sarvadi | Director, Chairman of the Board & CEO | Sale of securities on an exchange or to another person at price $ 84.04 per share. | 11 Feb 2025 | 15,108 | 446,476 (1%) | 0% | 84.0 | 1,269,676 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.